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Introduction: The area of secondary hyperalgesia following brief thermal sensitization (BTS) 
of the skin and heat pain detection thresholds (HPDT) may both have predictive abilities in 
regards to pain sensitivity and clinical pain states. The association between HPDT and second-
ary hyperalgesia, however, remains unsettled, and the dissimilarities in physiologic properties 
suggest that they may represent 2 distinctively different pain entities. The aim of this study 
was to investigate the association between HPDT and BTS-induced secondary hyperalgesia.
Methods: A sample of 121 healthy male participants was included and tested on 2 separate 
study days with BTS (45°C, 3 minutes), HPDT, and pain during thermal stimulation (45°C, 
1 minute). Areas of secondary hyperalgesia were quantified after monofilament pinprick stimula-
tion. The pain catastrophizing scale (PCS) and hospital anxiety and depression scale (HADS) 
were also applied.
Results: A significant association between HPDT and the size of the area of secondary hyper-
algesia (p<0.0001) was found. The expected change in area of secondary hyperalgesia due to 
a 1-degree increase in HPDT was estimated to be −27.38 cm2, 95% confidence interval (CI) of 
−37.77 to −16.98 cm2, with an R2 of 0.19. Likewise, a significant association between HADS-
depression subscore and area of secondary hyperalgesia (p=0.046) was found, with an estimated 
expected change in secondary hyperalgesia to a 1-point increase in HADS-depression subscore of 
11 cm2, 95% CI (0.19–21.82), and with R2 of 0.03. We found no significant associations between 
secondary hyperalgesia area and PCS score or pain during thermal stimulation.
Conclusion: HPDT and the area of secondary hyperalgesia after BTS are significantly associ-
ated; however, with an R2 of only 19%, HPDT only offers a modest explanation of the inter-
participant variation in the size of the secondary hyperalgesia area elicited by BTS.
Keywords: pain, central nervous system sensitization, hyperalgesia, pain threshold, healthy 
volunteers, catastrophization, secondary hyperalgesia, central sensitization
Introduction
Clinical pain models may bridge the gap between animal and human research and 
may be applied in the investigation of pain sensitivity. Sufficient prediction of pain 
sensitivity, for example prior to surgery, may improve our ability to prevent severe 
acute and chronic pain following surgery,1 as well improve the inclusion procedure 
in pharmaceutical drug trials by allowing initial grouping of participants in high- and 
low-pain responders.2,3
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Current evidence suggest that the development of sec-
ondary hyperalgesia to punctate mechanical stimuli after a 
cutaneous heat injury in healthy volunteers is mediated by 
heat- and mechanosensitive type-I and/or mechanosensi-
tive (heat-insensitive) A-fiber nociceptors, and is due to 
changes in the central nervous system, that is, central sen-
sitization.4–9 Central sensitization encompasses a functional 
change in neuron properties and nociceptive pathways, with 
increased membrane excitability and synaptic efficacy, 
and decreased synaptic inhibition resulting in increased 
and sometimes pathological responses to mechanical 
and noxious stimulation.4,9 The transcription-dependent 
long-lasting phase of central sensitization is assumed to 
play a key role in several pathological pain conditions, for 
example, osteoarthritis and fibromyalgia,4,9–11 and investi-
gation of secondary hyperalgesia following a standardized 
burn injury may therefore provide insight into central 
sensitization.
Studies in healthy volunteers have indicated that the size 
of the area of secondary hyperalgesia following standard-
ized cutaneous sensitization procedures has a large inter-
individual to intra-individual variance,12,13 is modifiable by 
certain analgesics,14–18 and may be predictive of individual 
pain responses.4,9,19,20 The area of secondary hyperalgesia 
following the cutaneous heat pain model of brief thermal 
sensitization (BTS)13,14,16,18,21,22 quantified by monofilament 
stimulation12–14,16–18,21–28 has been demonstrated to be a 
reproducible phenomenon that may be used in phenotype 
characterization of healthy volunteers.12,13
Heat pain detection threshold (HPDT) has been applied in 
several studies,17,18,22,25,29–33 and the acute first pain elicited by 
the rapid heating of the skin is believed to be transmitted in 
A-fiber type-II mechano- and heat-sensitive nociceptors (in 
hairy skin), and mechano- and heat-sensitive C fibers.5 HPDT 
has been proven to be reproducible,34 and evidence suggests 
that HPDT may have a predictive value when investigating 
postoperative pain.35,36
However, the dissimilarities in physiologic properties 
between secondary hyperalgesia to mechanical pinprick 
stimulation and HPDT suggest that they may represent 
2  distinctively different pain entities.
As a first step to explore secondary hyperalgesia fol-
lowing BTS and its potential predictive abilities, we aim to 
investigate the association between HPDT and secondary 
hyperalgesia induced by BTS. We hypothesized that HPDT 
and areas of secondary hyperalgesia were two predominantly 
independent entities, and that the area of secondary hyperal-
gesia was poorly explained by HPDT.
Methods
The study was approved by the local Danish Committee on 
Health Research Ethics for the Capital Region (Identifier: 
H-8-2014-012) and the Danish Data Protection Agency (Iden-
tifier: 30–1436); the study is also reported on the international 
database clinicaltrials.gov (Identifier: NCT02527395).
The design and methods of this prospective study is based 
upon a previous study done by Hansen et al;13 moreover, an 
extensive description of the design and methods of this study 
has been published in a preceding methods paper, which is 
publicly available for review.37
Study participants
Healthy male participants aged >18 and <35 years who could 
understand and speak the Danish language were included in 
the study. Written informed consent was obtained from all 
participants prior to inclusion, and all participants received 
EUR 20 (USD 27) per hour for their participation in the study. 
Participants were recruited by advertisement in the medical 
student magazine at Copenhagen University and online at 
www.forsøgspersoner.dk. Exclusion criteria were failure to 
cooperate with the tests, a weekly intake of >21 units of alco-
hol, consummation of >3 units of alcohol 24 hours before study 
day, substance abuse, intake of analgesics within 3 days before 
study day, intake of antihistamines 48 hours before study day, 
intake of prescription medicine and/or antidepressant medi-
cine within 30 days before study day, neurological illnesses, 
chronic pain conditions, psychiatric diagnoses, tattoos on the 
extremities, eczema, wounds or sunburns at the sites of testing, 
and a body mass index (BMI) of >30 kg/ m2 and <18 kg/m2.
Setting
The study was conducted in a quiet secluded room (temperature 
of 22°C–25°C), where only the investigator and the participant 
were present. The participants were placed in a supine position, 
on their back, throughout the assessments. The study was con-
ducted during the time from 8 AM to 6 PM at the Department of 
Anesthesiology, 4231, Rigshospitalet, Copenhagen, Denmark 
in the period from October 1, 2015 to December 2, 2015.
Design
The study consisted of 1 screening/information day and 
2  separate study days. To avoid a possible carry-over effect 
of the applied tests, the screening day and the 2 study days 
were separated with a minimum of 7 days.13 Height, weight, 
arterial blood pressure, and pulse frequency of all participants 
were measured; moreover, data on age, right/left-handedness, 
and parental ethnicity were collected. On the 2 separate 
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study days, the study participants were tested with 3 types 
of pain models: BTS, HPDT, and pain during 1-minute ther-
mal stimulation (p-TS) in a predefined sequence (see pain 
models and randomization and allocation concealment). On 
the information day, the participants were provided with the 
psychological tests, pain catastrophizing scale (PCS)38–40 
and hospital anxiety and depression scale (HADS)41–43 (see 
psychological testing), which they completed at home and 
returned on the first study day in sealed opaque envelopes to 
ensure blinding. Opening of the envelopes was deferred until 
all participants had completed the study. All other assess-
ments and tests were performed by the same investigator 
throughout the study (MSH).
Pain models
All pain testing was conducted with a computer-controlled 
thermode (MSA Thermotester™), size 2.5×5 cm
Brief thermal sensitization (BTS)
BTS was induced by placing the computer-controlled ther-
mode on the skin of the participant, centrally on the anterior 
part of the right thigh in the midline between the anterior 
superior iliac spine and the base of patella (Figure 1). The 
starting temperature of the thermode was 32°C, and with an 
increase of 1°C/second, the thermode was heated to 45°C. 
After 3 minutes, the assessment of secondary hyperalgesia 
(see below) was conducted while the thermode at 45°C was 
still positioned on the skin of the participant.14,16,18,21,22 The 
assessment of secondary hyperalgesia took ~1–2 minutes, 
resulting in a maximum duration of heat stimulation of 
5 minutes.
Assessment of secondary hyperalgesia
The area of secondary hyperalgesia was quantified after 
pinprick stimulation with a 19G monofilament (von Frey 
hair) in 4 linear paths arranged in 90° around the center of 
the thermode. Stimulation began well outside the area of 
secondary hyperalgesia, minimum 15 cm from the edge of 
the thermode, and advanced in steps of 5 mm/second toward 
the thermode. When the participant stated a clear change in 
sensation (intense burning, pricking, and tenderness), the 
spot was marked with a felt pen, and the longitudinal and 
transverse axes were measured with a pliable measuring tape 
for rectangular area calculation.12–14,16–18,21–28
Heat pain detection threshold (HPDT)
HPDT was evaluated by placing the thermode on the skin 
of the participant on the anterior part of the dominant lower 
arm (Figure 1). The start temperature of the thermode was 
32°C and the temperature was then increased by 1°C/second. 
When the participant perceived the heat as painful he pressed 
a button, the temperature was registered, and the thermode 
returned to a temperature of 32°C. If a temperature of 52°C 
was reached, the thermode would automatically return to 
32°C and 52°C would be registered as the threshold. The 
HPDT was estimated as an average of 4 separate stimulations 
with an interval of 6–10 seconds.13,14,16–18,22–25
Pain during thermal stimulation (p-TS)
The thermode was placed on the participant’s skin centrally 
on the anterior lower non-dominant arm (Figure 1). The 
start temperature of the thermode was 32°C, and with an 
increase of 1°C/second, the thermode was heated to 45°C and 
remained 45°C for 1 minute. During the 1 minute heating of 
the skin the participant evaluated the pain using the electronic 
visual analog scale (VAS; Somedic USB-VAS), with an 
index of 0–100 mm, where 0 mm represented “no pain”, and 
100 mm represented “worst pain imaginable”. The software 
provided with the electronic VAS automatically calculated 
an area under the curve (AUC) and a maximum VAS score 
for the time period. The participant was not able to see the 
computer screen during the assessment.17,22–25
Figure 1 Anatomical location of pain model testing.
Notes: HPDT was performed on the anterior part of the dominant lower arm, p-TS 
was performed on the anterior part of the non-dominant lower arm, and BTS was 
performed centrally on the anterior part of the right thigh in the midline between 
the anterior superior iliac spine and the base of patella.
Abbreviations: BTS, brief thermal sensitization; HPDT, heat pain detection 
threshold; p-TS, pain during thermal stimulation.
HPDT/p-TS
BTS
HPDT/p-TS
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Psychological testing
Pain Catastrophizing Scale (PCS)
PCS is 13-point questionnaire on a 5-point Likert scale 
with values from 0 to 4. The highest achievable score is 52, 
and the PCS can be subdivided into 3 sections that evaluate 
1) rumination, 2) magnification, and 3) helplessness.38–40
Hospital Anxiety and Depression Scale 
(HADS)
HADS is a 14-point questionnaire on a 4-point Likert scale 
with values ranging from 0 to 3. The highest achievable score 
is 53, and the HADS can be subdivided into 2 sections that 
evaluate 1) anxiety and 2) depression.41–43
Randomization and allocation 
concealment
The sequence of BTS and HPDT was randomized so that 
on 1 study day the sequence was: 1) BTS, 2) HPDT, and 
3) p-TS, and on the other study day the sequence was: 
1) HPDT, 2) BTS, and 3) p-TS. The randomization was 
performed with a computer-generated random allocation 
sequence, conducted by the Copenhagen Trial Unit, and 
stored in sealed opaque envelopes to secure adequate allo-
cation concealment.
Test results and assessments for each study day were 
entered in a standardized case report form and placed in an 
opaque sealed envelope to ensure that the investigator was 
unable to see previous test results. Completed psychological 
tests were kept in sealed opaque envelopes and the blinding 
was first broken after all study participants had completed 
the study.
Outcome measures
Primary analysis
The association between HPDT and area of secondary hyper-
algesia induced by BTS.
Secondary analyses
The association between area of secondary hyperalgesia 
induced by BTS and
1. VAS-AUC following p-TS
2. Max VAS-score following p-TS
3. PCS-score
4. HADS-score
5. PCS and HADS subscales (PCS-rumination, PCS-
magnification, PCS-helplessness, HADS-anxiety, and 
HADS-depression)
Sample size
A simulation-based sample size calculation was performed 
with data from our previous study;13 and with an α of 0.05 
and β of 0.01, we estimated that a number of 120 participants 
were needed in order to provide an empirical power of 99.9% 
(for further description see the published protocol37). All 
simulation-based calculations were made using the open-
source statistical programming environment R.44
Statistical analysis
Individual levels of areas of secondary hyperalgesia, HPDT, 
VAS-AUC, and VAS-max were obtained as estimated best 
linear unbiased predictors (EBLUPS). The association 
between area of secondary hyperalgesia and HPDT was 
evaluated by multiple linear regression adjusting for indi-
vidual body surface area. Models were validated graphically 
by means of residuals and QQ plots. Normality of residuals 
was assessed by the Kolmogorov–Smirnov test. The abil-
ity of HPDT to predict the size of the area of secondary 
hyperalgesia was quantified by R2 and illustrated with 
prediction limits.
In a secondary analysis, we additionally included VAS-
AUC, Max VAS-score following p-TS, PCS-score, and 
HADS-score as predictors in a multiple linear regression 
on area of secondary hyperalgesia. The importance of these 
predictors was assessed by backward elimination with a 5% 
cut-off level.
p-Values corresponded to F tests and were evaluated at 
a 5% significance level.
Additionally, 3 post hoc sensitivity analyses were per-
formed to assess the robustness of the findings. In the first 
sensitivity analysis, further adjustment by age, weight, BMI, 
and mean arterial pressure (MAP) was performed. In the 
second sensitivity analysis, only right-handed participants 
were included; and finally, in the third sensitivity analysis, 
only ethnic Scandinavians were included.
Body surface area was calculated using the Mosteller for-
mula.45 Distributions of variables are summarized by medians 
and interquartile ranges. All analyses were made using the 
open-source statistical programming environment R.44
Results
A sample of 131 healthy male volunteers was assessed for 
eligibility, and a total of 121 were included in the study 
( Figure 2). All 121 study participants completed the study, 
and data from all the participants were analyzed for the 
primary and secondary outcome measures. Of the 121 par-
ticipants, 12 had one or more parents with non-Scandinavian 
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Table 1 Characteristics of included participants
Characteristic Study participants (n=121)
Age (years)* 22 (20–24.5)
Height (m)* 1.84 (1.79–1.88)
Weight (kg)* 76.5 (70–85)
BMI (m2/kg)* 22.79 (20.9–24.5)
MAP (mmHg)* 89.6 (84.3–96)
Pulse (beats/min)* 64 (58–70)
Non-Scandinavian ethnicity (n) 12
Left-handed participants (n) 16
Note: *Data are reported as median and interquartile range.
Abbreviations: BMI, body mass index; MAP, mean arterial pressure.
Figure 2 Flowchart of included study participants.
Assessed for eligibility (n=131)
Not included (n=10)
Included in study (n=121)
Received interventions (n=121)
Analyzed (n=121)
Lost to follow-up (n=0)
Discontinued interventions (n=0)
Not meeting inclusion criteria (n=5)
Declined to participate (n=3)
Other reasons (n=2)
ethnicity and 16 were left-handed. The median interval 
between the 2 study days was 7 days (interquartile range 
[IQR], 7–8). Relevant data on the included participants’ 
characteristics are presented in Table 1. The median size of 
the area of secondary hyperalgesia was 447.78 cm2 (IQR, 
346.19–528.99) and the median HPDT was 45.57°C (IQR, 
43.79–46.61). Results from the p-TS, PCS, and HADS are 
presented in Tables 2 and 3. No adverse or serious adverse 
events were reported.
Primary analysis
We found a significant association between HPDT and the 
size of the area of secondary hyperalgesia (p<0.0001). We 
estimated the expected change in area of secondary hyperal-
gesia due to a 1-degree increase in HPDT to −27.38 cm2 with 
a 95% confidence interval (CI) of −37.77 to −16.98 cm2. The 
R2 was calculated to 0.19, and the prediction limits at a given 
HPDT of 46°C and body surface of 1.99 m2 were estimated 
to 167.42–656.07 cm2 (Figure 3).
Table 2 Results from pain model testing
Variable Median (IQR) Range (min–max)
Area of secondary 
hyperalgesia (cm2)
447.78 (346.19–528.99) 135.21–788.90
HPDT (°C) 45.57 (43.79–46.61) 38.70–51.01
p-TS VAS-max (mm) 32.82 (18.79–52.71) 2.41–95.99
p-TS VAS-AUC (mm2) 1123.92 (649.34–1844.45) 82.65–4456.32
Notes: Median and range were estimated by calculating the estimated best linear 
unbiased predictors (EBLUPS).
Abbreviations: HPDT, heat pain detection threshold; IQR, interquartile range; 
max, maximum; min, minimum; p-TS, pain during thermal stimulation; VAS-AUC, 
visual analog scale area under the curve; VAS-max, maximum visual analog scale.
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Secondary analyses
We found a significant association between HADS-depres-
sion score and area of secondary hyperalgesia (p=0.046). 
The estimated expected change in secondary hyperalgesia 
area to a 1-point increase in HADS-depression was 11 cm2 
(95% CI, 0.19–21.82; R2, 0.03). No significant associations 
were found in any of the other secondary outcome measures.
Post hoc analyses
The 3 post hoc sensitivity analyses did not demonstrate 
noticeably different results when compared to our primary 
analysis.
Discussion
In the present study, we aimed to investigate the associa-
tion between HPDT and secondary hyperalgesia elicited by 
BTS. We demonstrated a significant association between 
HPDT and secondary hyperalgesia, where increasing levels 
of HDPT were associated with decreasing sizes of second-
ary hyperalgesia areas. In addition to the highly significant 
association, we found an R2 of 19%, illustrating that HPDT 
only offers a modest explanation of the inter-participant 
variation in secondary hyperalgesia following BTS. The 
estimated prediction interval for areas of secondary hyper-
algesia at an HPDT of 46°C and a body surface of 1.99 m2 
were estimated to 167.42–656.07 cm2 (Figure 3), indicating 
that although we find a highly significant result, HPDT and 
areas of secondary hyperalgesia are only modestly associated. 
Likewise, we also found a significant association between 
increasing HADS-depression subscore and increasing size 
of secondary hyperalgesia area; however, R2 was estimated 
to 3%, and in this study, HADS-depression subscore only 
offered a very modest explanation for the variation in the 
area of secondary hyperalgesia.
We have applied an experimental pain model (BTS) with 
a high reliability (intraobserver intra-participant correlation 
of 0.85).13 Moreover, our post hoc sensitivity analyses did 
not demonstrate noticeable differences compared to our 
primary analysis, illustrating the robustness of our results. 
In our study, BMI, age, MAP, left-handedness, and ethnic-
ity did not have any influence on the association between 
HPDT and secondary hyperalgesia to mechanical punctate 
stimuli. The high number of included participants provides 
an empirical power of 99.9%, which practically eliminates 
the risk of type-II errors and once again illustrates the robust-
ness of our results.
The results in this study confirm the results from our 
previous study where a significant association was demon-
strated with an R2 of 20%.13 Likewise, in our current study we 
find a high inter-participant difference in areas of secondary 
hyperalgesia ranging from 135 to 788 cm2 (Table 2), as well 
as high inter-participant differences in HPDT ranging from 
38.7°C to 51.02°C (Table 2).
The weak association between HPDT and secondary 
hyperalgesia area is noteworthy because it has been sug-
gested that both parameters may to some extent be important 
in categorizing pain sensitivity; however, evidence on the 
predictive value of these parameters is contradicting with 
diverse results both for20,46–48 and against31,36 HPDT and 
secondary hyperalgesia areas as predictors of pain sensitiv-
ity. The physiologic properties in the neural mediation of 
HPDT and secondary hyperalgesia may, in part, account 
for the weak association. HPDT is primarily mediated by 
A-fiber type-II mechano- and heat-sensitive nociceptors, 
Table 3 Psychological test scores, total, and subscores
Variable Median (IQR) Range (min–max)
PCS-helplessness 4 (2–6.5) 0–17
PCS-rumination 5 (3–8) 0–12
PCS-magnification 3 (1–4) 0–10
PCS-total 12 (7–17) 1–31
HADS-anxiety 4 (2–6) 0–16
HADS-depression 1 (1–3) 0–13
HADS-total 6 (3–8.5) 0–21
Abbreviations: HADS, hospital anxiety and depression scale; IQR, interquartile 
range; PCS, pain catastrophizing scale.
Figure 3 Predictions of areas of secondary hyperalgesia (following BTS) by HPDT.
Notes: Points correspond to individual participant measurement of secondary 
hyperalgesia areas. The solid line corresponds to the predictions of secondary 
hyperalgesia areas and HPDT, and the dashed line corresponds to 95% prediction 
limits.
Abbreviations: BTS, brief thermal sensitization; HPDT, heat pain detection 
threshold.
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and mechano- and heat-sensitive C fibers, and secondary 
hyperalgesia to punctate mechanical stimuli is mediated by 
heat- and mechano-sensitive type-I and mechanosensitive 
(heat-insensitive) A-fiber nociceptors.5–7 In a recent study, 
results even suggested that secondary hyperalgesia was 
mediated only by heat-insensitive mechanosensitive A-fiber 
nociceptors.8 Finally, it is believed that the development of 
secondary hyperalgesia is caused by central sensitization due 
to changes in the central nervous system,4,7,9 which leads to 
the suggestion that HPDT and secondary hyperalgesia to 
mechanical punctate stimuli may be 2 distinctively different 
pain entities. A biological explanation, although specula-
tive, may be that HPDT represent an acute warning system 
against nociceptive stimuli, whereas secondary hyperalgesia 
represents a somewhat later occurrence of sensitization of 
central neurons, which may serve other purposes in the 
nociceptive process.
Studies have demonstrated that patients suffering from 
persistent pain due to rheumatoid arthritis or fibromyalgia 
display larger areas of secondary hyperalgesia when com-
pared with healthy individuals.49,50 Likewise, clinical studies 
have indicated that increasing sizes of secondary hyper-
algesia areas surrounding surgical wounds are associated 
with an increased risk of developing chronic pain follow-
ing surgery.20,51 These findings indicate that a large area of 
secondary hyperalgesia is found in persons with high levels 
of central sensitization. Thus, the investigation of second-
ary hyperalgesia areas may provide insight in individual 
levels of central sensitization. With Woolf’s description of a 
central sensitization syndrome,4 where pain hypersensitiv-
ity syndromes may share common contributions of central 
sensitization, the investigation of secondary hyperalgesia 
may provide insight into already known pain hypersensitivity 
syndromes, and may also contribute to the phenotyping of 
pain sensitivity in healthy persons. A recent brain magnetic 
resonance imaging study of healthy volunteers indicated 
that participants with differences in areas of secondary 
hyperalgesia exhibited structural and functional differences 
when comparing healthy participants with a large vs small 
area of secondary hyperalgesia,52 suggesting differences in 
sensory discrimination, pain suppression, and avoidance 
behavior. However, the practical applicability of secondary 
hyperalgesia areas is not yet fully understood or described, 
and thorough investigations of central sensitization, as well 
as factors influencing individual propensity to develop  central 
sensitization may have a role in the future of analgesic therapy 
and pain research.
Contrary to our previous study,13 we found a significant 
association between increasing HADS-depression subscore 
and increasing size of secondary hyperalgesia area. However, 
R2 was estimated to 3%, and in this study, HADS-depression 
subscore only offered a very modest explanation for the 
variation in secondary hyperalgesia areas. Several clinical 
studies have demonstrated significant associations between 
postoperative pain and personality traits, such as depression, 
anxiety, and pain catastrophizing.53–56 Moreover, in a study 
by Salomons et al,57 it was demonstrated that pain-focused 
cognitive training reduced the area of secondary hyperalge-
sia in healthy volunteers. However, in a recently published 
review it was concluded that the influence of psychological 
variables on experimental pain responses is still largely 
unclear.58 Our very strict inclusion criteria, that specifi-
cally excluded women, chronic pain patients, and persons 
with prior psychological history, may have resulted in a 
sampling bias that reduced the inter-individual variance of 
secondary hyperalgesia areas, PCS (IQR, 7–17), and HADS 
score (IQR, 3–8.5), and could be responsible for the weak 
association between HADS, HPDT, and secondary hyperal-
gesia. A  sufficient investigation of psychological variables 
and pain should attempt to conduct consecutive inclusion of 
patients prior to, for example, surgery or restricted inclusion 
of volunteers with high psychiatric vulnerability.
Our study has some limitations. 1) As emphasized before, 
we applied very strict inclusion criteria, and consequently, 
included a very homogenous population; inclusion of, for 
example, females and chronic pain patients could potentially 
have increased the inter-individual variance and resulted in a 
higher R2. However, individual characteristics, such as sex,25,59–62 
obesity,63 and menstrual hormone cycle,64 may potentially influ-
ence pain thresholds and sensitivity and to accommodate for 
all these variables, hereby minimizing the unknown factors of 
variation, and to focus only on the association between HPDT 
and secondary hyperalgesia areas, we chose to apply very strict 
inclusion criteria. Additionally, BTS has only been validated 
in healthy male volunteers,13 and consequently, the results of 
this study only apply to young and healthy, male volunteers.
2) We did not evaluate dietary intake, stress and hormone 
levels, genetics, brain anatomy, or skin receptor density of the 
included participants. Studies have suggested that diets high 
on tryptophan,65,66 high stress levels of serum cortisol and 
testosterone,67 and even certain genetic markers68–72 may influ-
ence the pain sensitivity. An inter-participant  differentiable 
diet and hormone level, as well as differences in stress levels, 
genetics, and brain anatomy could be explanatory factors 
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of the high inter-individual variance of HPDT and areas of 
secondary hyperalgesia.
Finally, 3 patients reported HPDTs well outside the 
interquartile ranges, 2 patients <40°C and 1 patient >50°C, 
which may indicate that they misunderstood the procedure.
In our study, HPDT only offered a modest explanation of 
the inter-individual size of the area of secondary hyperalgesia; 
and the inter-individual differences in secondary hyperalgesia 
observed in numerous studies remain largely unexplained. 
Studies investigating postoperative pain and secondary 
hyperalgesia before and after surgery could provide insight 
on the predictive value of secondary hyperalgesia areas, and 
finally, as secondary hyperalgesia is believed to occur as a 
result of central neuronal plasticity,4,9 future research should 
attempt to investigate variables in the central nervous system 
in both patients and healthy participants, with modalities 
such as structural and functional magnetic resonance imag-
ing, electroencephalography, and magnetoencephalography.
In conclusion, our study demonstrated a statistically 
significant association between HPDT and the size of the 
area of secondary hyperalgesia. However, with an R2 of only 
19%, HPDT offers only a modest explanation of the inter-
participant variation in the size of the secondary hyperalgesia 
area elicited by BTS.
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